Advertisement

Ad Code: 25664

Remnant Cholesterol a Marker for CV Outcomes in T2D

In patients with T2D, remnant cholesterol (remnant-C) levels were linked with major adverse cardiovascular events (MACE), independent of LDL-C, and remnant-C variability helped identify those at higher risk for cardiovascular...

Read More

What’s With HMOs’ Statin Therapy Obsession?

I’ve noticed a big push from HMO insurance companies for starting patients on statins. Basically, every patient with diabetes should be on this medication despite their lipid levels or other qualifying conditions, at least in...

Read More

For latest news and updates
Email-id is invalid